CIBC World Market
XBI icon

CIBC World Market’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CIBC World Market’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Buy
26,657
+7,134
+37% +$891K 0.01% 641
2025
Q4 		$2.38M Buy
19,523
+1,490
+8% +$171K ﹤0.01% 738
2025
Q3 		$1.81M Sell
18,033
-540
-3% -$48.6K ﹤0.01% 814
2025
Q2 		$1.54M Sell
18,573
-27,316
-60% -$2.18M ﹤0.01% 804
2025
Q1 		$3.72M Sell
45,889
-20,319
-31% -$1.82M 0.01% 565
2024
Q4 		$5.96M Sell
66,208
-11,162
-14% -$1.08M 0.01% 477
2024
Q3 		$7.64M Sell
77,370
-1,874
-2% -$184K 0.02% 389
2024
Q2 		$7.35M Sell
79,244
-8,767
-10% -$786K 0.02% 364
2024
Q1 		$8.35M Buy
88,011
+8,249
+10% +$765K 0.02% 346
2023
Q4 		$7.12M Buy
79,762
+284
+0.4% +$21.1K 0.02% 329
2023
Q3 		$5.8M Sell
79,478
-9,568
-11% -$764K 0.02% 346
2023
Q2 		$7.41M Buy
89,046
+31,663
+55% +$2.65M 0.02% 304
2023
Q1 		$4.37M Sell
57,383
-118,382
-67% -$9.82M 0.01% 397
2022
Q4 		$14.6M Buy
175,765
+64,142
+57% +$5.19M 0.05% 199
2022
Q3 		$8.85M Buy
111,623
+40,470
+57% +$3.41M 0.03% 251
2022
Q2 		$5.29M Sell
71,153
-29,784
-30% -$2.24M 0.02% 352
2022
Q1 		$9.07M Buy
100,937
+64,804
+179% +$5.98M 0.03% 264
2021
Q4 		$4.04M Buy
36,133
+16,953
+88% +$2.04M 0.01% 437
2021
Q3 		$2.41M Buy
19,180
+7,777
+68% +$1M 0.01% 534
2021
Q2 		$1.54M Sell
11,403
-28,336
-71% -$3.73M ﹤0.01% 675
2021
Q1 		$5.39M Buy
39,739
+3,185
+9% +$477K 0.02% 352
2020
Q4 		$5.15M Buy
36,554
+18,422
+102% +$2.36M 0.02% 357
2020
Q3 		$2.02M Buy
18,132
+4,491
+33% +$503K 0.01% 496
2020
Q2 		$1.53M Sell
13,641
-127
-0.9% -$12.5K 0.01% 543
2020
Q1 		$1.07M Buy
13,768
+9,363
+213% +$829K 0.01% 529
2019
Q4 		$419K Sell
4,405
-13,310
-75% -$1.15M ﹤0.01% 873
2019
Q3 		$1.35M Buy
17,715
+2,957
+20% +$246K 0.01% 563
2019
Q2 		$1.29M Sell
14,758
-16,693
-53% -$1.42M 0.01% 582
2019
Q1 		$2.85M Buy
31,451
+25,840
+461% +$2.2M 0.01% 419
2018
Q4 		$403K Sell
5,611
-38,351
-87% -$3.09M ﹤0.01% 836
2018
Q3 		$4.21M Sell
43,962
-24,164
-35% -$2.34M 0.02% 336
2018
Q2 		$6.49M Buy
68,126
+40,916
+150% +$3.76M 0.03% 246
2018
Q1 		$2.39M Buy
27,210
+5,907
+28% +$539K 0.01% 412
2017
Q4 		$1.81M Buy
21,303
+3,768
+21% +$316K 0.01% 326
2017
Q3 		$1.52M Sell
17,535
-19,620
-53% -$1.57M 0.01% 337
2017
Q2 		$2.87M Buy
37,155
+29,906
+413% +$2.12M 0.01% 384
2017
Q1 		$503K Buy
7,249
+19
+0.3% +$1.28K ﹤0.01% 743
2016
Q4 		$428K Sell
7,230
-19,377
-73% -$1.2M ﹤0.01% 842
2016
Q3 		$1.76M Buy
+26,607
New +$1.65M 0.01% 384
2013
Q4 		– Sell
-74,196
Closed -$3.19M – 714
2013
Q3 		$3.19M Buy
74,196
+33,798
+84% +$1.37M 0.01% 169
2013
Q2 		$1.4M Buy
+40,398
New +$1.42M 0.01% 254

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIBC World Market's XBI Position: Q1 2026 in Review

CIBC World Market increased its State Street SPDR S&P Biotech ETF (XBI) stake by 37% in Q1 2026, buying an estimated $891K and bringing the position to 26,657 shares worth $3.4M. The position accounts for 0.01% of the portfolio, ranked #641.

CIBC World Market first reported a position in XBI in Q2 2013 and has held it in 41 quarters since. The position peaked at $14.6M in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • CIBC World Market held 26,657 shares of State Street SPDR S&P Biotech ETF worth $3.4M as of Q1 2026.
  • CIBC World Market bought 7,134 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $891K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of CIBC World Market's portfolio in Q1 2026, its #641 holding.
  • CIBC World Market first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 41 quarters since.
  • CIBC World Market's State Street SPDR S&P Biotech ETF position peaked at $14.6M in Q4 2022.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.